1. ACHRE Archives, Record Group 42, National Archives II, 8601 Adeiphi Road, College Park, Maryland, 20740–6000, US. The sources contain material from the Department of Defence (DOD), the Department of Energy (DOE), corpo-rate (CORP) and independent sources (IND). A DOD entry, for example, would appear as DOD 042994-A;7116, which refers to source, date it was received, batch code, file number, and the total number of files in the batch.
2. Fisher B., Glass A., Redmond C., Fisher E. R., Barton B., Such E., Carbone P., Economou S., Foster R., Frelick R., Lerner H., Levitt M., Margolese R., MacFarlane J., Plotkin D., Shibata H. and Volk H. 1977, ‘L-Phenylalanine Mustard (L-PAM) in the Management of Primary Breast Cancer: An Update of Earlier Findings and a Comparison with Those Utilising L-PAM Plus 5-Fluorouracil (5—FU)’, Cancer, 39, 2883–903.
3. Kereiakes J. G., Van de Riet W., Born C., Ewing C., Silberstein E. and Saenger E. L. 1972, ‘Active Bone-Marrow Dose Related Hematological Changes in Whole-Body and Partial-Body Co-60 Gamma Radiation Exposures’, Radiology, 103, 651–6.
4. Saenger E. L. 1967, ‘Effects of Total- and Partial-Body Therapeutic Irradiation in Man’, Proceedings of 1
International Symposium on Biological Interpretation of Dose from Accelerator-Produced Radiation, University of California, Berkeley, March 13–16, 113–27.
5. Saenger E. L., Silberstein E. B., Aron B., Horwitz H., Kereiakes J. G., Bahr G. K., Perry H. and Friedman B. I. 1973, ‘Whole Body and Partial Body Radiotherapy of Advanced Cancer’, Am. J. Roentgenol. & Rad. Therapy, 117(3), 670–85.